SYGNATURE DISCOVERY

Serial Number 79410216
686

Registration Progress

Application Filed
Sep 12, 2024
Under Examination
Approved for Publication
Nov 25, 2025
Published for Opposition
Nov 25, 2025
Registered

Attorney Assistance

Published for Opposition
Due: Dec 25, 2025 6 days

Trademark Image

SYGNATURE DISCOVERY

Basic Information

Serial Number
79410216
Filing Date
September 12, 2024
Published for Opposition
November 25, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Nov 25, 2025
Application
Pending
Classes
001 040 042

Rights Holder

Sygnature Discovery Limited

99
Address
The Discovery Building Biocity,
Pennyfoot Street Nottingham, Nottinghamshire NG1 1GR
GB

Ownership History

Sygnature Discovery Limited

Original Applicant
99
GB

Sygnature Discovery Limited

Owner at Publication
99
GB

Legal Representation

Attorney
Molly T. Eichten

USPTO Deadlines

Next Deadline
6 days remaining
Published for Opposition
Due Date
December 25, 2025
Extension Available
Until January 25, 2026

Application History

16 events
Date Code Type Description Documents
Nov 25, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 25, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 19, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 27, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 24, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 24, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 24, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 9, 2025 RFNT P REFUSAL PROCESSED BY IB Loading...
Apr 24, 2025 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Apr 24, 2025 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 14, 2025 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Mar 13, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 12, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 25, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 25, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 21, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 001
Proteins for industrial use; proteins for use in manufacture; proteins for use in scientific research; proteins for use in the manufacture of pharmaceutical products; protein in raw material form for material science, agritech, cosmeceutical research; protein in raw material form for industrial use; protein in raw material form for use in manufacture; protein in raw material form for use in scientific research; protein in raw material form for use in the manufacture of pharmaceutical products.
Class 040
Processing of organic chemical liquids in the nature of chemical distillery services; recycling of organic solvents; purification of proteins; purification of proteins by chemical methods.
Class 042
Scientific research and development services; drug discovery services; development of pharmaceutical preparations and medicines; drug screening for scientific research purposes; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of human and veterinary pharmaceutical drugs; research relating to medicines; services for assessing the efficacy of human and veterinary pharmaceutical drugs, namely, human and veterinary pharmaceutical product evaluation, human and veterinary pharmaceutical drug discovery services; conducting early evaluations in the field of new pharmaceuticals; consultancy in the field of pharmaceutical research; consultancy relating to pharmaceutical research and developments; development of pharmaceutical preparations and medicines; inspection of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and drug development; research and development in the pharmaceutical and drug development fields; testing of pharmaceutical drugs; assay development services being custom design and development of biophysical, biochemical, cell-based, phenotypic, in-vitro and in-vivo, assays; biological research; biological analysis; biological research laboratory services; biological research, clinical research in the field of immunotherapy, cancerous diseases, respiratory diseases, neuroscience, fibrotic diseases, metabolic diseases and infectious diseases and medical research; consultancy relating to pharmacology; medical and pharmacological research services; scientific research for medical purposes in the field of immunotherapy, cancerous diseases, respiratory diseases, neuroscience, fibrotic diseases, metabolic diseases and infectious diseases; research in the field of synthetic biology; research and development in the field of microorganisms and cells; chemical research and analysis services; chemical engineering; chemistry services, namely, laboratory research in the field of chemistry; medicinal, synthetic, analytical and high throughput chemistry services, namely, hit generation and optimization, lead optimisation, scale up manufacture, metabolite, analogue, impurity, and analytical standard synthesis and/or isolation and purification, structure elucidation; clinical research in the field of immunotherapy, cancerous diseases, respiratory diseases, neuroscience, fibrotic diseases, metabolic diseases and infectious diseases; organic chemistry research and analysis services; consultancy in the field of organic chemistry; laboratory research and analysis services in the field of organic chemistry; research and development services in the field of organic chemistry; development, testing and analysis of chemicals; development, testing and analysis of chemical production methods; protein and peptide mapping for scientific purposes; scientific analysis services, namely, scientific analysis of materials for human and veterinary pharmaceutical, material science, agritech, cosmeceutical research for scientific research purposes; protein analysis services for scientific purposes; scientific research in the field of protein sequencing; protein crystallisation screening for scientific purposes; quality control for others; testing of materials; product testing; technological research in the field of immunotherapy, cancerous diseases, respiratory diseases, neuroscience, fibrotic diseases, metabolic diseases and infectious diseases; industrial analysis and research services in the field of immunotherapy, cancerous diseases, respiratory diseases, neuroscience, fibrotic diseases, metabolic diseases and infectious diseases; scientific services relating to cell line generation; scientific screening services being ion channel screening, iterative screening, fragment screening and in silico screening, for scientific research purposes; compound profiling and selectivity services; X-ray and cryoelectronmicroscopy imaging and NMR structure determination of proteins, biological macromolecules and molecules, other than for medical purposes; blood analysis services for scientific research purposes; information, advisory and consultancy services relating to the aforesaid services.

Additional Information

Pseudo Mark
SIGNATURE DISCOVERY

Classification

International Classes
001 040 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DISCOVERY"